| Metric | Q2'25 | Q3'25 | Change |
|---|---|---|---|
| Revenue (FTE) | $25.5B (Q2) | $28.2B (Q3) | +$2.7B linked quarter, +11% YoY acceleration |
| EPS | $0.83 (Q2) | $1.06 (Q3) | +$0.23 linked quarter, +31% YoY vs +7% prior quarter |
| NII (FTE) | $14.8B (Q2) | $15.4B (Q3) | +$572M linked quarter, record level |
| Operating Leverage | Negative (Q2) | 560 bps (Q3) | Major reversal to strong positive leverage |
| Efficiency Ratio | 65% (Q2) | 62% (Q3) | 300 bps improvement, below 62% target |
| Return on Tangible Common Equity | 13.4% (Q2) | 15.4% (Q3) | +200 bps acceleration approaching peer targets |
| Investment Banking Fees | $1.4B (Q2) | $2.0B+ (Q3) | +43% YoY, highest non-pandemic quarter |
| Sales & Trading Revenue | Strong (Q2) | $5.3B ex-DVA (Q3) | +8% YoY, 14th consecutive quarter of growth |
| Consumer Banking Net Income | $2.7B (Q2) | $3.4B (Q3) | +28% YoY with 600 bps operating leverage |
| Global Wealth Net Income | $1.1B (Q2) | $1.3B (Q3) | +19% YoY, 26% return on allocated capital |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.